The Japan-Multinational Trial Organization

Pretreatment neutrophil count as an independent prognostic factor in advanced non-small-cell lung cancer: An analysis of Japan Multinational Trial Organisation LC00-03

Satoshi Teramukai, Toshiyuki Kitano, Yusuke Kishida et al. · European Journal of Cancer · 2009 · 339 citations

Advanced Lung Disease, Medicine, Immunology +7

Transurethral Prostatectomy: Practice Aspects of the Dominant Operation in American Urology

H. Logan Holtgrewe, Winston K. Mebust, Joseph B. Dowd et al. · The Journal of Urology · 1989 · 308 citations

Pelvic Reconstructive Surgery, Surgery, Physician Reimbursement +16

Chemotherapy-induced neutropenia as a prognostic factor in advanced non-small-cell lung cancer: results from Japan Multinational Trial Organization LC00-03

Yusuke Kishida, Mutsuto Kawahara, Satoshi Teramukai et al. · British Journal of Cancer · 2009 · 83 citations · Full text

Vinorelbine plus gemcitabine followed by docetaxel versus carboplatin plus paclitaxel in patients with advanced non-small-cell lung cancer: a randomised, open-label, phase III study

Kaoru Kubota, Masaaki Kawahara, Mitsumasa Ogawara et al. · The Lancet Oncology · 2008 · 76 citations

Oncology, Pharmacology, Pharmacotherapy +7

Interstitial lung disease in gefitinib-treated Japanese patients with non-small cell lung cancer – a retrospective analysis: JMTO LC03-02

Masatsugu Nakagawa, Tsutomu Nishimura, Satoshi Teramukai et al. · BMC Research Notes · 2009 · 22 citations · Full text